Friday, April 10, 2026 | 09:46 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Zydus receives USFDA approval for Erythromycin Tablets

BBC apologises to Princess Diana aide over interview deceit

Capital Market
  • Kal Somani has taken full ownership of IPL’s Rajasthan Royals, valuing the Jaipur franchise at about $1.6–1.63B. Beating The Times Group, Somani, formerly a minority holder, now leads a consortium backed by Walmart-linked investors and US business families, acquiring 100%.
Did our AI summary help?
Let us know.
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Erythromycin Tablets USP, 250 mg and 500 mg (USRLD: Erythromycin Tablets).

Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body, including respiratory tract infections, skin infections, diphtheria, intestinal amebiasis, acute pelvic inflammatory disease, legionnaire's disease, pertussis and syphilis. The drugs will be manufactured at the group's formulation manufacturing facility in Moraiya, Ahmedabad (India).

Erythromycin Tablets USP, 250 mg and 500 mg had annual sales of USD 25.1 mn in the United States (IQVIA MAT Dec. 2022).

 

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 09 2023 | 4:20 PM IST

Explore News